Tech Company Financing Transactions
Chromis Funding Round
Torrey Pines Investment and private investors participated in a $3 million Seed funding round for Chromis. The financing round was announced by the company on 2/29/2016.
Transaction Overview
Company Name
Announced On
2/29/2016
Transaction Type
Venture Equity
Amount
$3,000,000
Round
Seed
Investors
Torrey Pines Investment (Lead Investor)
Proceeds Purpose
The company intends to use the funds to advance its platform of antiviral drugs, including cccDNA inhibitors, entry inhibitors and capsid assembly inhibitors, for the treatment of the Hepatitis B virus (HBV).
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
12760 High Bluff Dr.
San Diego, CA 92130
USA
San Diego, CA 92130
USA
Phone
Undisclosed
Website
Email Address
Overview
A biopharmaceutical company, focused on the development of treatments for chronic HBV infection, based on advanced drug design and discovery platform.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Scientific Officer
Vadim Bichko
VP - R & D
Mira Huyghe
Browse more venture capital transactions:
Prev: 2/29/2016: Terbium Labs venture capital transaction
Next: 2/29/2016: iCharts venture capital transaction
Share this article
News on VC Transactions
We report on every notable VC transaction. All VC database entries on this site are sourced from publicly available VC deal announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs